Lupus conference? I have read that announcement. It's great.
But NOX are acting like kids in a chemistry lab. No sense of urgency and no awareness of current market conditions.
Have a play with COVID. Have a play with inflammation. With pancreatic cancer. With Lupus. With mRNA vaccines.
None of these plays with a near term viable commercial strategy.
All the while, basically ignoring the only asset that has a snowballs chance in hell of funding their pipeline.
Ann: Noxopharm Announces Novel mRNA Vaccine Enhancer, page-14
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.58M | |||
| Open | High | Low | Value | Volume |
| 6.7¢ | 7.2¢ | 6.6¢ | $7.387K | 106.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26900 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 12345 | 1 |
View Market Depth
| Last trade - 14.24pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.7¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.7¢ | 6.7¢ | 6.7¢ | 21117 | ||
| Last updated 14.24pm 14/06/2024 ? | |||||
| NOX (ASX) Chart |